Kawamoto Yusuke, Ome Yusuke, Koda Yusuke, Saga Kenichi, Kawamoto Kazuyuki, Ito Tadashi
Dept. of Surgery, Kurashiki Central Hospital.
Gan To Kagaku Ryoho. 2016 Jan;43(1):125-8.
A 75-year-old woman presented with right upper quadrant abdominal pain and anorexia. She was diagnosed with descending colon cancer with lymph node and liver metastases. She was treated with preoperative chemotherapy consisting of levofolinate/5-fluorouracil/oxaliplatin (mFOLFOX6). After the completion of 7 courses of chemotherapy, the tumor shrunk remarkably. A left-sided colectomy with radical lymphadenectomy and an extensive posterior segment resection of the liver were performed. Postoperatively, pathological analysis revealed no cancerous cells in the primary tumor, lymph node metastases, or liver metastases. She is currently receiving mFOLFOX6 therapy as adjuvant chemotherapy. In a patient with advanced colon cancer, a complete response of not only the primary tumor but also the lymph node and liver metastases to preoperative chemotherapy is rare. This case demonstrates that mFOLFOX6 therapy is safe and effective as preoperative chemotherapy for advanced colon cancer.
一名75岁女性因右上腹腹痛和厌食就诊。她被诊断为降结肠癌伴淋巴结和肝转移。她接受了由亚叶酸钙/5-氟尿嘧啶/奥沙利铂(mFOLFOX6)组成的术前化疗。在完成7个疗程的化疗后,肿瘤显著缩小。进行了左侧结肠切除术加根治性淋巴结清扫术以及肝脏广泛后段切除术。术后,病理分析显示原发肿瘤、淋巴结转移灶或肝转移灶均无癌细胞。她目前正在接受mFOLFOX6治疗作为辅助化疗。在晚期结肠癌患者中,原发肿瘤以及淋巴结和肝转移灶对术前化疗均出现完全缓解的情况很罕见。该病例表明,mFOLFOX6治疗作为晚期结肠癌的术前化疗是安全有效的。